TKPHF - Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q3 2022 Results - Earnings Call Transcript
Takeda Pharmaceutical Company Limited. (TAK) Q3 2022 Earnings Conference Call February 3, 2022 6:00 am ET Corporate Participants Christopher O’Reilly - Global Head, IR & Global Finance Christophe Weber - President and Chief Executive Officer Andy Plump - President Research and Development Costa Saroukos - Chief Financial Officer Masato Iwasaki - Japan General Affairs Ramona Sequeira - President, U.S. Business Unit and Global Portfolio Commercialization Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Hidemaru Yamaguchi - Citi Stacy Ku - Cowen Stephen Barker - Jefferies Seiji Wakao - JPMorgan Fumiyoshi Sakai - Credit Suisse Shinichiro Muraoka - Morgan Stanley Presentation Operator Thank very much for joining our fiscal year 2021 Third Quarter Earnings announcement. I am the moderator and I’m Chris O'Reilly, the head of Global IR. And we have the interpretation button at the bottom of that Zoom. And if you'd like to listen to Japanese,
For further details see:
Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q3 2022 Results - Earnings Call Transcript